Dr. New is the founder and CEO of Radyus Research. As an experienced drug developer with a background in early-stage venture capital, large pharma R&D, and university technology transfer, she brings invaluable business acumen and extensive international connections to Radyus.

Dr. New’s previous roles as a partner at Agent Capital, principal investor at Baxalta Ventures, commercial lead at Baxter International’s renal franchise, and entrepreneur in residence at Northwestern University have helped her establish the foundation for the work done at Radyus.

Dr. New received her PhD from the University of Illinois at Chicago, completed a postdoctoral fellowship at Northwestern and received an MBA at Kellogg School of Management.